Analytical Data
-
Gene name
STRADA
- Application
-
Alternative Names
LYK5; STRAD
-
Species
Human
-
Source
Baculovirus
-
Tag
His;GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7RTN6-1
-
Expression Region
S2-F431
-
Protein Length
Partial
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
STRADA (STRADα, or STE20-related adaptor protein) is a crucial component in the regulation of the mTOR signaling pathway, which is integral to cellular growth, metabolism, and proliferation. Recent studies have highlighted the importance of STRADA in various physiological and pathological processes, including cancer progression and metabolic disorders. Research indicates that STRADA functions as a molecular adaptor, connecting kinases and other signaling molecules, thus facilitating essential cellular responses to environmental stimuli. Its role in modulating mTOR activity positions STRADA as a potential therapeutic target, especially in diseases characterized by dysregulated cell growth and metabolism. The exploration of STRADA's structure and function through protein reconstitution techniques has opened avenues for developing novel pharmacological agents aimed at modulating its activity. Understanding the intricate mechanisms by which STRADA influences cellular signaling pathways can lead to innovative strategies in treating diseases linked to mTOR dysregulation, making it a significant focus within the fields of molecular biology and drug discovery.
